Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial have?
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial has 10 citations in the OpenAlex counts ScholarIQ stores.
When was Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial published?
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial has 2023 year in the ScholarIQ index.
What is the open-access status of Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial?
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial?
The DOI for Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial is on the source record.
What is the PMID of Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial?
The PMID for Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial is on the source record.
What is the OpenAlex record for Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial?
The OpenAlex for Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial is on the source record.